Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Company Profiles: Prescient Therapeutics Limited
Company Profiles: Prescient Limited
The Biotech Investor
Author: Tom Abate
Publisher: Times Books
ISBN: 146685121X
Category : Business & Economics
Languages : en
Pages : 308
Book Description
A sophisticated investor's practical tool kit for analyzing the science, business, opportunities, and risks in the century's most promising industry The world is entering a biotechnology boom-but only informed investors will prosper in the incredibly complex biotech business. Separating the bioengineered wheat from the chaff, San Francisco Chronicle science and technology columnist Tom Abate, one of the top objective authorities on biotech, gives investors the analytical foundation to understand the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. In The Biotech Investor, Abate provides sophisticated business analysis, guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He explains how breaking news, medical conferences, U.S. Food and Drug Administration approvals, and the patent process affect investing strategies. Finally, he looks beyond medicine to review the financial opportunities presented by biotechnology advances in everything from agriculture to jean manufacturing, and shows investors how to identify "coattail" industries such as instrumentation and software development that will benefit from biotech successes. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.
Publisher: Times Books
ISBN: 146685121X
Category : Business & Economics
Languages : en
Pages : 308
Book Description
A sophisticated investor's practical tool kit for analyzing the science, business, opportunities, and risks in the century's most promising industry The world is entering a biotechnology boom-but only informed investors will prosper in the incredibly complex biotech business. Separating the bioengineered wheat from the chaff, San Francisco Chronicle science and technology columnist Tom Abate, one of the top objective authorities on biotech, gives investors the analytical foundation to understand the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. In The Biotech Investor, Abate provides sophisticated business analysis, guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He explains how breaking news, medical conferences, U.S. Food and Drug Administration approvals, and the patent process affect investing strategies. Finally, he looks beyond medicine to review the financial opportunities presented by biotechnology advances in everything from agriculture to jean manufacturing, and shows investors how to identify "coattail" industries such as instrumentation and software development that will benefit from biotech successes. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.
Official Gazette of the United States Patent and Trademark Office
Who Owns Whom
Thomas Register of American Manufacturers
Author:
Publisher:
ISBN:
Category : Industrialists
Languages : en
Pages : 2156
Book Description
Vols. for 1970-71 includes manufacturers catalogs.
Publisher:
ISBN:
Category : Industrialists
Languages : en
Pages : 2156
Book Description
Vols. for 1970-71 includes manufacturers catalogs.
Mergent Complete Corporate Index
Brain Tumors E-Book
Author: Andrew H. Kaye
Publisher: Elsevier Health Sciences
ISBN: 0702048186
Category : Medical
Languages : en
Pages : 931
Book Description
Meet the increasing need for effective brain tumor management with the highly anticipated revision of Brain Tumors by Drs. Andrew H. Kaye and Edward R. Laws. Over the past decade, enormous advances have been made in both the diagnosis and the surgical and radiotherapeutic management of brain tumors. This new edition guides you through the latest developments in the field, including hot topics like malignant gliomas, functional brain mapping, neurogenetics and the molecular biology of brain tumors, and biologic and gene therapy. Benefit from the knowledge and experience of Drs. Andrew H. Kaye and Edward R. Laws, globally recognized experts in the field of neurosurgery, as well as many other world authorities.
Publisher: Elsevier Health Sciences
ISBN: 0702048186
Category : Medical
Languages : en
Pages : 931
Book Description
Meet the increasing need for effective brain tumor management with the highly anticipated revision of Brain Tumors by Drs. Andrew H. Kaye and Edward R. Laws. Over the past decade, enormous advances have been made in both the diagnosis and the surgical and radiotherapeutic management of brain tumors. This new edition guides you through the latest developments in the field, including hot topics like malignant gliomas, functional brain mapping, neurogenetics and the molecular biology of brain tumors, and biologic and gene therapy. Benefit from the knowledge and experience of Drs. Andrew H. Kaye and Edward R. Laws, globally recognized experts in the field of neurosurgery, as well as many other world authorities.
Standard & Poor's Register of Corporations, Directors and Executives
Author: Standard and Poor's Corporation
Publisher:
ISBN:
Category : Capitalists and financiers
Languages : en
Pages : 926
Book Description
This principal source for company identification is indexed by Standard Industrial Classification Code, geographical location, and by executive and directors' names.
Publisher:
ISBN:
Category : Capitalists and financiers
Languages : en
Pages : 926
Book Description
This principal source for company identification is indexed by Standard Industrial Classification Code, geographical location, and by executive and directors' names.